Tag: magrolimab
Gilead suspends trials of its anticancer drug magrolimab
(AOF) – Gilead announced Thursday the suspension of registrations to test its anticancer drug, magrolimab, on solid tumors. This decision comes a week after the American regulator suspended certain studies…